Democrats and Republicans accused drugmakers of taking advantage of patents to keep cheaper competition off the market.
  • Jackcooper@lemmy.world
    6·
    1 month ago

    The PBMs and their back room rebates are largely to blame. There’s legislation that passed the house to bring more light to these but the Senate won’t put it on the floor.